Thank you, Mr. Chair.
I'd like to propose amendment G-14, which would amend clause 39. This motion essentially seeks to clarify the policy intent in clause 39 and the associated clause 14 in Bill S-5, introducing a new enabling authority under 66.1 to allow the minister to add substances on Health Canada's Revised In Commerce List to the domestic substances list under CEPA, to reflect the fact that they are in Canadian commerce.
The intent was to include only those substances that were on the Revised In Commerce List and not removed by the list identified in my motion—which is the “removal of substances with no commercial activity from the Revised In Commerce List” published in the Canada Gazette—and that have no conditions on them.
The feedback that has been received by the government since then was that this was vague and open to interpretation, so this motion aims to clearly articulate the policy intent. That is more or less the explanation of it.
Thanks.